Manganese porphyrin reduces retinal injury induced by ocular hypertension in rats

Experimental Eye Research

Volumn 93, Issue 4, 2011, Pages 387-396

  Dogan, Serdar ^a   Unal, Mustafa ^a   Ozturk, Nihal ^a   Yargicoglu, Piraye ^a   Cort, Aysegul ^a   Spasojevic, Ivan ^b   Batinic Haberle, Ines ^b   Aslan, Mutay ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Manganese porphyrin; MnTnHex 2 PyP 5+; Nitric oxide synthase; Ocular hypertension; SOD mimic

Indexed keywords

ANTIOXIDANT; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE; NITRATE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PORPHYRIN; PORPHYRIN MANGANESE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EVOKED VISUAL RESPONSE; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LIQUID CHROMATOGRAPHY; MALE; NEUROPROTECTION; NICK END LABELING; NITRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA INJURY; TANDEM MASS SPECTROMETRY;

ANIMALS; ANTIOXIDANTS; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EVOKED POTENTIALS, VISUAL; IN SITU NICK-END LABELING; INJECTIONS, INTRAPERITONEAL; INTRAOCULAR PRESSURE; ISOTHIURONIUM; MALE; METALLOPORPHYRINS; NITRATES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; OCULAR HYPERTENSION; OXIDATIVE STRESS; RATS; RATS, WISTAR; RETINA; RETINAL DISEASES; TANDEM MASS SPECTROMETRY; VITREOUS BODY;

EID: 80052147100     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2011.05.008     Document Type: Article

References (56)

1. Akpinar D., Yargicoglu P., Derin N., Aslan M., Agar A. Effect of aminoguanidine on visual evoked potentials (VEPs), antioxidant status and lipid peroxidation in rats exposed to chronic restraint stress. Brain Res. 2007, 1186:87-94.
2. Aslan M., Cort A., Yucel I. Oxidative and nitrative stress markers in glaucoma. Free Radic. Biol. Med. 2008, 45:367-376.
3. Aslan M., Ryan T.M., Townes T.M., Coward L., Kirk M.C., Barnes S., Alexander C.B., Rosenfeld S.S., Freeman B.A. Nitric oxide-dependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerization. J. Biol. Chem. 2003, 278:4194-4204.
4. Aslan M., Yücel I., Akar Y., Yücel G., Ciftçioĝlu M.A., Sanlioglu S. Nitrotyrosine formation and apoptosis in rat models of ocular injury. Free Radic. Res. 2006, 40:147-153.
5. Aslan M., Yucel I., Ciftcioglu A., Savas B., Akar Y., Yucel G., Sanlioglu S. Corneal protein nitration in experimental uveitis. Exp. Biol. Med. (Maywood) 2007, 232:1308-1313.
6. Batinić-Haberle I., Rebouças J.S., Spasojević I. Superoxide dismutase mimics: chemistry, pharmacology, and therapeutic potential. Antioxid. Redox Signal. 2010, 13:877-918.
7. - dismutation. J. Chem. Soc. Dalton Trans. 2002, 2689-2696.
8. Bazan N.G., Marcheselli V.L., Cole-Edwards K. Brain response to injury and neurodegeneration: endogenous neuroprotective signaling. Ann. N. Y. Acad. Sci. 2005, 1053:137-147.
9. Cort A., Ozturk N., Akpinar D., Unal M., Yucel G., Ciftcioglu A., Yargicoglu P., Aslan M. Suppressive effect of astaxanthin on retinal injury induced by elevated intraocular pressure. Regul. Toxicol. Pharmacol. 2010, 58:121-130.
10. De La Paz M.A., Epstein D.L. Effect of age on superoxide dismutase activity of human trabecular meshwork. Invest. Ophthalmol. Vis. Sci. 1996, 37:1849-1853.
11. Derin N., Akpinar D., Yargicoglu P., Agar A., Aslan M. Effect of alpha-lipoic acid on visual evoked potentials in rats exposed to sulfite. Neurotoxicol. Teratol. 2009, 31:34-39.
12. Fechtner R.D., Weinreb R.N. Mechanisms of optic nerve damage in primary open angle glaucoma. Surv. Ophthalmol. 1994, 39:23-42.
13. Ferreira S.M., Lerner S.F., Brunzini R., Evelson P.A., Llesuy S.F. Oxidative stress markers in aqueous humor of glaucoma patients. Am. J. Ophthalmol. 2004, 137:62-69.
14. Ferrer-Sueta G., Vitturi D., Batinic-Haberle I., Fridovich I., Goldstein S., Czapski G., Radi R. Reactions of manganese porphyrins with peroxynitrite and carbonate radical anion. J. Biol. Chem. 2003, 278:27432-27438.
15. Ferrer-Sueta G., Radi R. Chemical biology of peroxynitrite: kinetics, diffusion, and radicals. ACS Chem. Biol. 2009, 4:161-177.
16. Gaasterland D., Tanishima T., Kuwabara T. Axoplasmic flow during chronic experimental glaucoma. 1. Light and electron microscopic studies of the monkey optic nervehead during development of glaucomatous cupping. Invest. Ophthalmol. Vis. Sci. 1978, 17:838-846.
17. Gherghel D., Griffiths H.R., Hilton E.J., Cunliffe I.A., Hosking S.L. Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 2005, 46:877-883.
18. Gottanka J., Johnson D.H., Martus P., Lütjen-Drecoll E. Severity of optic nerve damage in eyes with POAG is correlated with changes in the trabecular meshwork. J. Glaucoma 1997, 6:123-132.
19. Graham S.L., Klistorner A. Electrophysiology: a review of signal origins and applications to investigating glaucoma. Aust. N. Z. J. Ophthalmol. 1998, 26:71-85.
20. Hall A., Karplus P.A., Poole L.B. Typical 2-Cys peroxiredoxins - structures, mechanisms and functions. FEBS J. 2009, 276:2469-2477.
21. Heneka M.T., Loschmann P.A., Gleichmann M., Weller M., Schulz J.B., Wullner U., Klockgether T. Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factoralpha/lipopolysaccharide. J. Neurochem. 1998, 71:88-94.
22. Herr D.W., King D., Barone S., Crofton K.M. Alterations in flash evoked potentials (FEPs) in rats produced by 3,30-iminodipropionitrile (IDPN). Neurotoxicol. Teratol. 1995, 17:645-656.
23. Howe J.W., Mitchell K.W. Visual evoked potential changes in chronic glaucoma and ocular hypertension. Trans. Ophthalmol. Soc. U. K. 1986, 105(Pt 4):457-462.
24. Hu J., Van Eldik L.J. S100 beta induces apoptotic cell death in cultured astrocytes via a nitric oxide-dependent pathway. Biochim. Biophys. Acta 1996, 1313:239-245.
25. Ischiropoulos H., Gow A. Pathophysiological functions of nitric oxide-mediated protein modifications. Toxicology 2005, 208:299-303.
26. Izzotti A. DNA damage and alterations of gene expression in chronic-degenerative diseases. Acta Biochim. Pol. 2003, 50:145-154.
27. Izzotti A., Sacca S.C., Cartiglia C., De Flora S. Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am. J. Med. 2003, 114:638-646.
28. Jia L., Cepurna W.O., Johnson E.C., Morrison J.C. Effect of general anesthetics on IOP in rats with experimental aqueous outflow obstruction. Invest. Ophthalmol. Vis. Sci. 2000, 41:3415-3419.
29. Keir S.T., Dewhirst M.W., Kirkpatrick J.P., Bigner D.D., Batinic-Haberle I. Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors. Anticancer Agents Med. Chem. 2011, 11:202-212.
30. Kim Y.M., Bombeck C.A., Billiar T.R. Nitric oxide as a bifunctional regulator of apoptosis. Circ. Res. 1999, 84:253-256.
31. Kos I., Rebouc-as J.S., De Freitas-Silva G., Salvemini D., Vujaskovic Z., Dewhirst M.W., Spasojevic I., Batinic-Haberle I. The effect of lipophilicity of porphyrin-based antioxidants. Comparison of ortho and meta isomers of Mn(III) N-alkylpyridylporphyrins. Free Radic. Biol. Med. 2009, 47:72-78.
32. Lehman D.M., Harrison J.M. Flash visual evoked potentials in the hypomyelinated mutant mouse shiverer. Doc. Ophthalmol. 2002, 104:83-95.
33. Li F., Sonveaux P., Rabbani Z.N., Liu S., Yan B., Huang Q., Vujaskovic Z., Dewhirst M.W., Li C.Y. Regulation of HIF-1alpha stability through S-nitrosylation. Mol. Cell. 2007, 26:63-74.
34. Liu B., Neufeld A.H. Expression of nitric oxide synthase-2 (NOS-2) in reactive astrocytes of the human glaucomatous optic nerve head. Glia 2000, 30:178-186.
35. Miyamoto N., Izumi H., Miyamoto R., Kubota T., Tawara A., Sasaguri Y., Kohno K. Nipradilol and timolol induce Foxo3a and peroxiredoxin 2 expression and protect trabecular meshwork cells from oxidative stress. Invest. Ophthalmol. Vis. Sci. 2009, 50:2777-2784.
36. Neufeld A.H., Sawada A., Becker B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:9944-9948.
37. Nieminen T., Lehtimäki T., Mäenpää J., Ropo A., Uusitalo H., Kähönen M. Ophthalmic timolol: plasma concentration and systemic cardiopulmonary effects. Scand. J. Clin. Lab. Invest. 2007, 67:237-245.
38. Okado-Matsumoto A., Batinic-Haberle I., Fridovich I. Complementation of SOD-deficient Escherichia coli by manganese porphyrin mimics of superoxide dismutase activity. Free Radic. Biol. Med. 2004, 37:401-410.
39. Quigley H.A., Addicks E.M. Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest. Ophthalmol. Vis. Sci. 1980, 19:137-152.
40. Saccà S.C., Izzotti A., Rossi P., Traverso C. Glaucomatous outflow pathway and oxidative stress. Exp. Eye Res. 2007, 84:389-399.
41. Saccà S.C., Pascotto A., Camicione P., Capris P., Izzotti A. Oxidative DNA damage in the human trabecular meshwork: clinical correlation in patients with primary open-angle glaucoma. Arch. Ophthalmol. 2005, 123:458-463.
42. Sarih M., Souvannavong V., Adam A. Nitric oxide synthase induces macrophage death by apoptosis. Biochem. Biophys. Res. Commun. 1993, 191:503-508.
43. Sawada A., Neufeld A.H. Confirmation of the rat model of chronic, moderately elevated intraocular pressure. Exp. Eye Res. 1999, 69:525-531.
44. Schroeder C.E., Tenke C.E., Givre S.J., Arezzo J.C., Vaughan H.G. Striate cortical contribution to the surface-recorded pattern-reversal VEP in the alert monkey. Vision Res. 1991, 31:1143-1157.
45. Shareef S., Sawada A., Neufeld A.H. Isoforms of nitric oxide synthase in the optic nerves of rat eyes with chronic moderately elevated intraocular pressure. Invest. Ophthalmol. Vis. Sci. 1999, 40:2884-2891.
46. Shareef S.R., Garcia-Valenzuela E., Salierno A., Walsh J., Sharma S.C. Chronic ocular hypertension following episcleral venous occlusion in rats. Exp. Eye Res. 1995, 61:379-382.
47. Sheng H., Spasojevic I., Tse H.M., Jung J.Y., Hong J., Zhang Z., Piganelli J., Batinic-Haberle I., Warner D.S. Neuroprotective efficacy from parenteral administration of a redox-modulating lipophilic Mn porphyrin, MnTHex-2-PyP5+. J. Pharmacol. Exp. Ther. Jun 2011, 7. [Epub ahead of print].
48. Silver S., Sohmer H., Kapitulnik J. Visual evoked potential abnormalities in jaundiced Gunn rats treated with sulfadimethoxine. Pediatr. Res. 1995, 38:258-261.
49. Spasojevic I., Kos I., Benov L.T., Rajic Z., Fels D., Dedeugd C., Ye X., Vujaskovic Z., Reboucas J.S., Leong K.W., Dewhirst M.W., Batinic-Haberle I. Bioavailability of metalloporphyrin-based SOD mimics is greatly influenced by a single charge residing on a Mn site. Free Radic. Res. 2011, 45:188-200.
50. Tezel G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog. Retin. Eye Res. 2006, 25:490-513.
51. Tezel G., Yang X. Caspase-independent component of retinal ganglion cell death. Invest. Ophthalmol. Vis. Sci. 2004, 45:4049-4059.
52. Tezel G., Yang X., Cai J. Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma. Invest. Ophthalmol. Vis. Sci. 2005, 46:3177-3187.
53. Towle V.L., Moskowitz A., Sokol S., Schwartz B. The visual evoked potential in glaucoma and ocular hypertension: effects of check size, field size, and stimulation rate. Invest. Ophthalmol. Vis. Sci. 1983, 24:175-183.
54. Tse H.M., Milton M.J., Piganelli J.D. Mechanistic analysis of the immunomodulatory effects of a catalytic antioxidant on antigen-presenting cells: implication for their use in targeting oxidation-reduction reactions in innate immunity. Free Radic. Biol. Med. 2004, 36:233-247.
55. Yücel I., Yücel G., Akar Y., Demir N., Gürbüz N., Aslan M. Transmission electron microscopy and autofluorescence findings in the cornea of diabetic rats treated with aminoguanidine. Can. J. Ophthalmol. 2006, 41:60-66.
56. Zhou L., Li Y., Yue B.Y. Oxidative stress affects cytoskeletal structure and cell-matrix interactions in cells from an ocular tissue: the trabecular meshwork. J. Cell. Physiol. 1999, 180:182-189.